A structured crystalline framework of lactose monohydrate used as a carrier and diluent in pharmaceutical tablet manufacturing.
The lactose crystal matrix is a precisely engineered crystalline structure composed of pharmaceutical-grade lactose monohydrate particles arranged in a specific geometric configuration. This component serves as the primary excipient in tablet formulations, providing structural integrity, uniform drug distribution, and controlled dissolution properties. The matrix is designed with optimal particle size distribution (typically 50-200 μm), specific surface area, and crystalline morphology to ensure consistent compaction behavior, flow characteristics, and bioavailability enhancement in final pharmaceutical products.
诱因 → 失效模式 → 工程缓解
不是客户评论，也不是实时热度。以下维度用于前期 RFQ 准备和供应商评估。
这些分值是采购评估维度示例，不代表真实客户评分、具体国家买家反馈或实时询盘。
The lactose crystal matrix serves as the primary excipient in tablet formulations, providing structural support, uniform drug distribution, controlled dissolution properties, and consistent compaction behavior during tablet manufacturing processes.
Optimal particle size distribution (50-200 μm) ensures consistent flow properties, uniform die filling, homogeneous mixing with active ingredients, and predictable compaction behavior, resulting in tablets with consistent weight, hardness, and dissolution profiles.
Store in sealed containers at controlled room temperature (15-25°C) with relative humidity below 60%. Protect from moisture absorption and contamination. Shelf life is typically 36 months from manufacturing date when stored properly.
CNFX 是开放目录，不是交易平台或采购代理。工厂资料和表单用于帮助你准备直接沟通。
CNFX 制造商资料、技术分类、公开产品信息和持续合理性检查。
说明目标数量、应用场景、交期和关键技术要求，用于准备 RFQ 或供应商评估。